Panacea Life Sciences Holdings, Inc. Other Asset Impairment Charges
Panacea Life Sciences Holdings, Inc. (PLSH) reported Other Asset Impairment Charges of $4.58 million for the 12-month period ending 2020-12-31, per its 10-K/A filed 2021-04-23.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OtherAssetImpairmentCharges · last filed 2021-04-23
- Panacea Life Sciences Holdings, Inc. other asset impairment charges for the quarter ending 2016-09-30 was $0.00, a 100.00% decline year-over-year.
- Panacea Life Sciences Holdings, Inc. other asset impairment charges for the quarter ending 2015-09-30 was $10.20K.
- Panacea Life Sciences Holdings, Inc. other asset impairment charges for the quarter ending 2015-06-30 was $10.20K.
- Panacea Life Sciences Holdings, Inc. other asset impairment charges for fiscal 2020 was $4.58M, a 1729.56% increase from fiscal 2019.
- Panacea Life Sciences Holdings, Inc. other asset impairment charges for fiscal 2019 was $250.19K.
| Period end | Other Asset Impairment Charges 3 month | Other Asset Impairment Charges 6 month | Other Asset Impairment Charges 9 month | Other Asset Impairment Charges 12 month | Other Asset Impairment Charges 12 month as first filed |
|---|---|---|---|---|---|
| 2020-12-31 | $4.58M 10-K/A · filed 2021-04-23 | ||||
| 2019-12-31 | $250.19K 10-K/A · filed 2021-04-23 | $0.00 10-K · filed 2021-04-15 | |||
| 2016-09-30 | $0.00 10-Q · filed 2016-11-14 | $0.00 10-Q · filed 2016-11-14 | |||
| 2015-09-30 | $10.20K 10-Q · filed 2015-11-06 | $20.40K derived: sum of 2 quarters · filed 2016-11-14 | $10.20K 10-Q · filed 2016-11-14 | ||
| 2015-06-30 | $10.20K 10-Q · filed 2016-11-14 |